The board of directors appointed Mr. Njaal Kind as acting CEO of Gentian Diagnostics ASA. Mr. Kind joined Gentian in January 2018 as CFO. More recently he has been promoted to CFO/COO.

During these years at Gentian, Mr. Kind has significantly contributed to the outstanding financial performance of the company. As acting CEO, Mr. Kind will also continue to serve as CFO and COO. The company?s general meeting has resolved to elect Ms. Hilja Ibert as chairperson of the board of directors.

Ms. Ibert has therefore resigned as CEO effective April 29, 2024.